Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Most patients experienced significant but reversible hair loss during treatment.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Valproic acid is an effective seizure medication with some temporary side effects.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Baricitinib was effective in treating both early and late onset alopecia areata.

Dermatological drugs and cosmetics can cause serious side effects like cancer, allergies, and heart issues.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

The new drug delivery system effectively targets lung cancer cells.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib may help treat severe hair loss, but more research is needed.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.